The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Mirum Pharmaceuticals Inc shares valued at $117,752 were sold by Howe Jolanda on Nov 14 ’24. At $47.10 per share, Howe Jolanda sold 2,500 shares. The insider’s holdings dropped to 2,426 shares worth approximately $98495.6 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Heron Patrick J purchased 115 shares, netting a total of over 4,301 in proceeds. Following the buying of shares at $37.40 each, the insider now holds 162,308 shares.
Before that, Heron Patrick J had added 230 shares to its account. In a trade valued at $9,563, the Director bought Mirum Pharmaceuticals Inc shares for $41.58 each. Upon closing the transaction, the insider’s holdings increased to 230 shares, worth approximately $6.59 million.
As published in their initiating research note from Stifel on April 17, 2024, Mirum Pharmaceuticals Inc [MIRM] has been a Buy and the price target has been revised to $48. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in mid December. Earlier on November 13, 2023, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for MIRM stock.
Analyzing MIRM Stock Performance
During the last five days, there has been a drop of approximately -6.90%. Over the course of the year, Mirum Pharmaceuticals Inc shares have jumped approximately 37.53%. Shares of the company reached a 52-week high of $48.89 on 11/14/24 and a 52-week low of $23.14 on 04/25/24. A 50-day SMA is recorded $41.92, while a 200-day SMA reached $34.97. Nevertheless, trading volume fell to 0.55 million shares from 0.28 million shares the previous day.
Support And Resistance Levels for Mirum Pharmaceuticals Inc (MIRM)
According to the 24-hour chart, there is a support level at 39.49, which, if violated, would cause prices to drop to 38.39. In the upper region, resistance lies at 42.24. The next price resistance is at 43.89. RSI (Relative Strength Index) is 38.02 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.97, which suggests the price will decrease in the coming days. Percent R is at 91.91%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
